/ /

Lynda Charters
Clinical Round Up: No glaucoma protection from primary IOL placement in children
Clinical Round Up: No glaucoma protection from primary IOL placement in children
In this month's Clinical Round Up, Sharon Freedman, MD, discusses results of the Infant Aphasia Treatment Study, and how it found there is no glaucoma protection from primary IOL placement in children. Additionally, Barbara Parolini, MD, discusses the new hope for better myopic traction maculopathy outcomes.
Unraveling the complex role of perfusion pressure in glaucoma progression
Low perfusion pressure is a risk factor for glaucoma, however, the understanding of the role of perfusion pressure in the disease must be clarified.
Targeting TGF-beta in different ocular diseases
A potent and selective transforming growth factor (TGF)-β2 LNA-modified antisense oligonucleotide induces biologic responses consistent with the drug’s expected molecular mechanism of action in different preclinical ocular surface disease models.
Cutting-edge LASIK technologies in quest for perfect vision
Take-home message: The various excimer ablation technologies have their pros and cons. Wavefront-guided ablations using aberrometry can provide the vast majority of patients with uncorrected vision of 20/20 with fewer postoperative visual symptoms.
Referral criteria trumps screening technology for amblyopia
Physicians should focus on referral criteria in screening technology rather than the instrument itself.
Combo therapy improves VA in AMD patients
Anti-vascular endothelial growth factor (anto-VEGF) monotherapy is inadequate in patients with age-related macular degeneration (AMD). However, by adding an anti-platelet-derived growth factor (anti-PDGF) drug to the anti-VEGF regimen, treatment is enhanced by preventing the development of fibrosis thus improving visual outcomes, according to Usha Chakravarthy, MBBS, PhD.
Dropless cataract surgery yields postoperative prophylaxis for patients, practices
Dropless cataract surgery—a combination of anti-infective and anti-inflammatory drugs injected transzonularly or through the pars plana for deposit into the vitreous—reduces the need for topical postoperative drops.
Novel metric may determine ectasia risk
Using a new metric seems to be an easy way to determine a patient’s risk of developing ectasia after a refractive procedure, according to Marcony R. Santhiago, MD, PhD.
High-res device gives retinal imaging a facelift
Retinal disease has been given a new face thanks to increased details of the adaptive optics scanning laser ophthalmoscope (AO-SLO), according to Mina Chung, MD.
Novel accommodative IOL shows stable visual function over 18 months
Fluid-based accommodating IOL technology achieved “true accommodation” in a pilot study. A multicenter study of the lens is ongoing.

Poll

View Results